hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 21:35:54 - browse：41

1:01Former President and Republican presidential candidate Donald Trump prepares to deliver remarks at a Nevada Republican volunteer recruiting event, July 8, 2023, in Las Vegas.Mario Tama/Getty Images

The federal judge overseeing the case involving former President Donald Trump's handling of classified documents after leaving office has agreed to delay an upcoming hearing in the case.

Judge Aileen Cannon agreed Tuesday to delay a hearing involving how to handle classified material in special counsel Jack Smith's prosecution of Trump and his valet, Walt Nauta.

The hearing, originally scheduled for Friday, July 14, will now occur on Tuesday, July 18.

MORE: Trump seeks lengthy delay of classified docs trial, citing upcoming election

Nauta's attorney, Stanley Woodward, had requested the delay due to a timing conflict with a bench trial he has to attend as defense counsel for a defendant charged in the Justice Department's investigation of the Jan. 6 Capitol attack.

On Monday, Smith's top prosecutor, Jay Bratt, urged Judge Cannon to reject the request, arguing that Nauta can be properly represented by his new local attorney, Sasha Dadan.

"There is a strong public interest in the conference occurring as originally scheduled and the case proceeding as expeditiously as possible," Bratt said in his filing.

PHOTO: Former President and Republican presidential candidate Donald Trump prepares to deliver remarks at a Nevada Republican volunteer recruiting event, July 8, 2023, in Las Vegas. — Former President and Republican presidential candidate Donald Trump prepares to deliver remarks at a Nevada Republican volunteer recruiting event, July 8, 2023, in Las Vegas.Mario Tama/Getty Images

The move comes as Trump's attorneys seek a lengthy delay of the trial, suggesting in a filing on Monday that it would not be possible to try the case prior to the 2024 election.

Trump pleaded not guilty last month to 37 criminal counts related to his handling of classified materials, after prosecutors said he repeatedly refused to return hundreds of documents containing classified information ranging from U.S. nuclear secrets to the nation's defense capabilities.

Nauta, Trump's longtime aide, last week pleaded not guilty to six counts related to the case, including conspiracy to obstruct justice and making false statements.

Trump has denied all charges and denounced Smith's probe as a political witch hunt.

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Who gets to use the title 'doctor'?

WSS

FDA authorizes Novavax’s updated Covid

A virus, fished out of a lake, may have saved a man’s life

Grail faces three suits alleging harassment, retaliation

Physician executives need more than on

Celiac disease study examines precisely how gluten triggers injury

Stroke deaths set to near 10 million globally by 2050

knowledge

hotspot

MORE: Trump seeks lengthy delay of classified docs trial, citing upcoming election

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

United colonoscopy coverage change 'may cost lives,' doctors say

Phenylephrine and the overlooked value of the placebo effect

State Dept. review finds Biden bears some blame for Afghanistan failures

Mike Pence clashes with Tucker Carlson in Iowa

Peter Hotez and the public health issue of online harassment

J&J expands global access to TB drug amid advocacy campaign

Drug repurposing or repositioning? The language matters

Bill would stop addiction treatment from triggering child abuse inquiry

hotspot

What to expect at HLTH 2023, the health care industry conference

Why police arrested suspected Gilgo Beach killer away from his house

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Georgia court denies Trump's request to quash DA's 2020 election probe

Mike Pence clashes with Tucker Carlson in Iowa

FDA panel signals lack of confidence in Amgen cancer drug data

focus

hotspot

focus

focus